<b>Methods:</b> wt and GLS1-silenced triple negative breast cancer spheroids were treated with 3-TYP, a selective SIRT3 inhibitor, and with MC3138, a new selective SIRT5 activator, both alone and in combination. The gene discussed is SIRT3; the disease is triple-negative breast carcinoma.